On March 27, 2026, Picard Medical, Inc. submitted an 8-K filing with the SEC, detailing a Regulation FD disclosure. This filing, identified by SEC Accession No. 0001829126-26-002794, includes information relevant to investors and stakeholders regarding the company's operations and financial status as of March 25, 2026. The filing is part of the company's ongoing commitment to transparency and compliance with SEC regulations. The document outlines key items including Item 7.01, which pertains to Regulation FD disclosures, and Item 9.01, which includes financial statements and exhibits. The filing is accessible through the SEC's EDGAR database, providing stakeholders with the necessary information to assess the company's current standing. As part of the filing, various documents and graphics were included to support the disclosures made. The company continues to uphold its governance and compliance standards, ensuring that all relevant information is communicated effectively to its investors.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.